MNKD Mannkind Corp

MannKind Corp is a development stage biotech firm. It is engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer.

$4.71  +0.19 (4.09%)
As of 06/24/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/28/2004
Outstanding shares:  249,157,354
Average volume:  4,062,988
Market cap:   $1,111,241,799
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    56400P706
ISIN:        US56400P7069
Sedol:      BF081J4
Valuation   (See tab for details)
PE ratio:   -18.51
PB ratio:   -4.37
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy